Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03330158

Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child

The purpose of this biomedical research is to evaluate the feasibility of the treatment with the new spinal distraction device ASTS in patients aged 4 to 10 years with severe early onset scoliosis.

The hypothesis of this project is that the new fully implantable motorized spinal distraction device may provide a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.

The ASTS (for Active Scoliosis Treatment System) growing rod is a new fully implantable motorized spinal distraction device which can ensure a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

4 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Toulouse

Toulouse, 31000, France

About this study

Despite a better understanding and technical progress, the evolutionary early scoliosis remains a therapeutic challenge. The definition includes idiopathic scoliosis beginning before the age of 3 years, congenital scoliosis, neuromuscular and syndromic. Spinal deformity is often progressive and may compromise cardiorespiratory function.

The goal of treatment is to prevent further avoiding spinal fusion in a subject in growth. Surgery is indicated in case of failure or cons-indication of conservative treatment (corset or plaster). The principle is to position the posterior rods subcutaneous or in muscle attached to two ends of the deformation.

Intraoperative distraction allows correction of the deformity. A new distraction is performed every 6 months until skeletal maturity.

Considerable complication rates are reported (58%), mainly implant infections and disassembly, because of the need for multiple reoperations. Motorized implants can potentially avoid repeated interventions limiting complications.

Thus, the central hypothesis of this project is a new fully implantable motorized spinal distraction device may provide a correction of scoliosis and progressive elongation ensuring patient comfort and minimizing complications.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient 4 to 10 years
  • Patient weight between 15kg at 50kg
  • Introducing severe scoliosis (Cobb angle> 40 °) with early onset
  • Failed or cons-indication of conservative treatment (cast or brace)
  • Agreement of parents or legal guardian (written agreement) and the patient (at least an oral agreement).

Exclusion criteria

  • Contraindication to surgery
  • Age less than 4 years or above 10 years
  • Weight less 15kg and above 50 kg

Treatment and study plan

ASTS

Device

Implantation of a motorized spinal distraction rod

Primary outcomes

  1. Ability to Implant the device

    Time frame: Day 0: the day of the implantation

    The surgeon will have to say if the implantation of the device has been done or not

  2. Change of the position of the implant

    Time frame: 1 years after the implantation

    1 year after the implantation of the device, radiographs will be realised to ensure that the implant is still well positioning

  3. Change of the position of the implant

    Time frame: 2 years after the implantation

    2 years after the implantation of the device, radiographs will be realised to ensure that the implant is still weel positioning

  4. Change of the position of the implant

    Time frame: 3 years after the implantation

    3 years after the implantation of the device, radiographs will be realised to ensure that the implant is still weel positioning

  5. Change of the implant's length

    Time frame: 3 months, 6 months, 9 months, 1 year, 2 years and 3 years after the implantation

    The elongation of the implant will be measured in mm on the digital radiography

Secondary outcomes

  1. Post-surgical pain

    Time frame: 3 months, after the implantation

    Self-assessment of pain using a visual analog scale

  2. Post-surgical pain

    Time frame: months after the implantation

    Self-assessment of pain using a visual analog scale

  3. Post-surgical pain

    Time frame: 9 months after the implantation

    Self-assessment of pain using a visual analog scale

  4. Post-surgical pain

    Time frame: 1 year after the implantation

    Self-assessment of pain using a visual analog scale

  5. Survey to evaluate the quality of life

    Time frame: Day 0

    Assess quality of life in the questionnaire PedsQL

  6. Survey to evaluate the quality of life

    Time frame: 6 months after the implantation

    Assess quality of life in the questionnaire PedsQL

  7. Survey to evaluate the quality of life

    Time frame: 1 year after the implantation

    Assess quality of life in the questionnaire PedsQL

  8. to ease for the surgeon to implant the device,

    Time frame: Day 0

    Number of participant with ease for the surgeon to implant the device,

  9. wound closure without tension,

    Time frame: Day 0

    Number of participant with closure of the wound without tension,

  10. good positioning of the radiographic implant.

    Time frame: Day 0

    Number participant with good positioning of the radiographic implant.

  11. Number of medical visits

    Time frame: 1 year

    Measure of the number of medical visit in the year after implant

  12. Determine the number of iterative extensions made during follow-up

    Time frame: 1 year

    Number of iterative extensions of 1 year.

  13. correction of deformation immediately after the operation,

    Time frame: 3 months, 6 months, 9 month and 1 year

    Number of participant with correction of deformation immediately after the operation,

  14. correction of deformation immediately after the operation,

    Time frame: 3 months after implantation

    Number of participant with correction of deformation immediately after the operation,

  15. Loss correction at 1 year

    Time frame: 6 months after implantation

    Loss correction at 1 year

  16. Loss correction at 1 year

    Time frame: 9 month after implantation

    Loss correction at 1 year

  17. Loss correction at 1 year

    Time frame: 1 year after implantation

    Loss correction at 1 year

  18. Increase the distance T1-S1 at 1 year

    Time frame: 1 year

    Increase the distance T1-S1 at 1 year (in mm)

  19. Effective Elongation measured on radiographs of specification of the device (in mm)

    Time frame: 3 months after implantation

    Effective Elongation measured on radiographs of specification of the device (in mm)

  20. Effective Elongation measured on radiographs of specification of the device

    Time frame: 6 months after implantation

    Effective Elongation measured on radiographs of specification of the device (in mm)

  21. Effective Elongation measured on radiographs of specification of the device

    Time frame: 9 month after implantation

    Effective Elongation measured on radiographs of specification of the device (in mm)

  22. Effective Elongation measured on radiographs of specification of the device

    Time frame: 1 year after implantation

    Effective Elongation measured on radiographs of specification of the device (in mm)

  23. Nature of complications

    Time frame: 1 years

    describe the nature of complication

  24. Nature of complications

    Time frame: 2 years

    describe the nature of complication

  25. Nature of complications

    Time frame: 3 years

    describe the nature of complication

  26. Nature of complications

    Time frame: 5 years

    describe the nature of complication

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Acronym: ASTS

Important dates

Study start
2019
Primary completion
2025
Study completion
2025
First posted
Nov 6, 2017
Registry last updated
Sep 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.